Ali-Jackson Kamil Insider Trades

Insider Trading History

Track insider trading activity for Ali-Jackson Kamil. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $461k 12,625 shares
Last Trade
May 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$72.9k 2,500 shares
$29.17
$36.52
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $552k 15,125 shares
Last Trade
May 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 5,750 shares
$29.01
$36.52
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $48k 54,876 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.8k 54,876 shares
$0.98
$0.87
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $19.8k 22,700 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.7k 22,700 shares
$1.75
$0.87
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $342k 9,375 shares
Last Trade
May 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.9k 3,000 shares
$18.95
$36.52
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $7.86k 9,000 shares
Last Trade
Jun 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.7k 9,000 shares
$2.86
$0.87
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $2.51M 68,750 shares
Last Trade
May 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 30,000 shares
$9.07
$36.52
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $7.86k 9,000 shares
Last Trade
Jul 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.2k 9,000 shares
$5.13
$0.87
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $1.6M 43,750 shares
Last Trade
May 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$396k 30,000 shares
$13.20
$36.52
PDS Biotechnology
PDS Biotechnology PDSB
Director
Holding Value $7.86k 9,000 shares
Last Trade
Jun 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.1k 9,000 shares
$3.90
$0.87
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $822k 22,500 shares
Last Trade
May 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$452k 22,500 shares
$20.10
$36.52
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director
Holding Value $4.38M 120,000 shares
Last Trade
Dec 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.93M 120,000 shares
$24.40
$36.52
PDS Biotechnology
PDS Biotechnology PDSB
Holding Value $7.86k 9,000 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.6k 9,000 shares
$9.95
$0.87
PDS Biotechnology
PDS Biotechnology PDSB
Holding Value $10.3k 11,764 shares
Last Trade
Jun 15, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$100k 11,764 shares
$8.50
$0.87
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Chief Legal Officer
Holding Value $585k 122,196 shares
Last Trade
Jun 03, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$208k 9,492 shares
$21.96
$4.79
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Chief Legal Officer
Holding Value $715k 149,324 shares
Last Trade
Jun 02, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$652k 30,119 shares
$21.64
$4.79
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Chief Legal Officer
Holding Value $0 0 shares
Last Trade
Jun 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$785k 33,189 shares
$23.64
$4.79
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Chief Legal Officer
Holding Value $800k 167,061 shares
Last Trade
Jun 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$345k 15,000 shares
$23.02
$4.79
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Chief Legal Officer
Holding Value $847k 176,807 shares
Last Trade
Jun 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$785k 33,189 shares
$23.64
$4.79
Aclaris Therapeutics
Aclaris Therapeutics ACRS
Chief Legal Officer
Holding Value $0 0 shares
Last Trade
May 07, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$124k 5,416 shares
$22.95
$4.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up